Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-12
2011-10-04
Kosack, Joseph (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S397000, C514S341000, C514S256000, C514S365000, C514S333000, C514S342000, C548S333500, C548S314400, C548S200000, C548S315400, C548S312400, C546S274700, C546S256000, C546S269700, C544S333000, C544S310000
Reexamination Certificate
active
08030339
ABSTRACT:
This invention relates to novel imidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment therewith.The compounds of the invention are useful in the treatment of central nervous system diseases and disorders, which are responsive to modulation of the GABAAreceptor complex, and in particular for combating anxiety and related diseases.
REFERENCES:
patent: 4952698 (1990-08-01), Biere et al.
patent: WO-88/01268 (1988-02-01), None
patent: WO-03/093263 (2003-11-01), None
patent: WO-2004/041809 (2004-05-01), None
Ahring Philip K.
Brown David Tristram
Brown William Dalby
Larsen Janus S.
Mirza Naheed
Birch & Stewart Kolasch & Birch, LLP
Coughlin Matthew
Kosack Joseph
Neurosearch A/S
LandOfFree
Imidazole derivatives for the treatment of anxiety and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole derivatives for the treatment of anxiety and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives for the treatment of anxiety and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4285147